Sunday, November 1, 2026

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

MO $130B

Invariant Nov 1 2 clicks

Nov 1 CRWD $248B

Sleep Well Portfolio (Oct 2026) - SWI#25 and #26 Adding Exposure to AI.

Sleep Well Investments 7 clicks

Nov 1 TGOPF $33B

Portfolio Update October 2026

D Invests 3 clicks

From X

@finphysnerd Nov 1 1 click

Myles on X

$AAPL is a pretty straightforward short here imo. Even ignoring the ridiculous valuation, it's become a flight to safety stock. If we get a proper market crash I can't see it continuing to hold up, meanwhile if we get a recover in the Q's we likely see a rotation out.

@BarbarianCap Nov 1 1 click

Barbarian Capital on X

7/n $BSP CEO @luke10ferrari on Joys of Compounding @Buhrman_Rick ⁠@PaulBuser⁠ Sounds like a very thoughtful operator, not that he needs my opinion https://t.co/Xwd1Namvk8

@finphysnerd Nov 1 3 clicks

Myles on X

I think $HONA looks pretty attractive here. Some execution risk, but this is fundamentally a fantastic business that is experiencing short term issues, while experiencing spinoff selling and hedge fund degrossing. I think it's hard to lose too much money here.

@negligible_cap Nov 1 2 clicks

Negligible Capital on X

Wonder when $META will do the same for Muse. They obviously can sustain it a lot longer than SpaceX but Muse (as Zuck noted on their call) is very expensive Have seen sell side putting around $180 / year cost estimates per user in the free tier. Not cheap https://t.co/j1RqQzdZpZ

@ParadisLabs Nov 1 1 click

Paradis on X

Pretty crazy: $AAPL is now negatively correlated to $QQQ for the first time ever. The market is treating Apple as a safe haven from AI capex. https://t.co/KnzKu2Fpff

@finphysnerd Nov 1 2 clicks

Myles on X

Had no $META position for the whole of September and October, but I think I'm going to be picking up some again this week. Been talking to a lot of people in advertising and I think a lot of investors really underestimate just how powerful their ads business is. Nasdaq https://t.co/4YcupLeKKu

@junkbondinvest Nov 1 3 clicks

junkbondinvestor on X

Crazy chart that puts things into context. US bonds issued by Amazon, Alphabet, Meta, Microsoft and Oracle: 2024: <$17bn 2025: $93bn 2026 YTD: $182 BILLION 10 of the 21 largest bond deals ever were done this year. $MSFT $AMZN $GOOGL $META $ORCL https://t.co/PCO7m8heFi

@StableBread Nov 1

Fajasy on X

I found no named data center or space customer, and no disclosed revenue from either, in TOYO Co., Ltd’s $TOYO filings, releases, or decks, even though its pitch increasingly mentions AI and space. The mentions are then-CEO Junsei Ryu’s November 2024 line about grid demand from “data centers, electric vehicles, and industry,” CEO Takahiko Onozuka’s May 2026 plan for a U.S. R&D center to help “power the AI economy,” a Citi $C investor webcast on space and AI on July 8, and “data-center applications” among the end markets for the ~$240M of module contracts, with no dollar split. The space pitch rests on the HJT (heterojunction) cells $TOYO plans to make in Texas. The slides CTO Dr. Aihua Wang and Chief Technical Advisor Dr. Jianhua Zhao presented at the Citi webcast priced HJT modules at $0.46/W, vs. $70-170/W for the multi-junction cells satellites use today. But HJT cells turn only 20% of sunlight into power in space, vs. 30-34% for multi-junction cells, and the same slides say efficiency matters more than cost in space, since a more efficient cell gets more power from the same payload. $TOYO’s Analyst Day deck later called the comparison “an internal technology evaluation” and “not a disclosed business line.” Rhone Resch, $TOYO’s Chief Strategy Officer, still told analysts that “every single data center that goes up in space is going to be solar powered.” Data centers and space add no disclosed revenue today, and none of my valuation cases counts new business from either, which, if you were being optimistic, makes them a free option on a cell technology $TOYO doesn’t yet produce.

Agnico Eagle: Soaring Above The Peer Group

Agnico Eagle expects low-end 2026 guidance despite Barnat setbacks, while Hope Bay, Upper Beaver and Odyssey support production above 4…

AEM $84B

Taylor Dart Nov 1 3 clicks

Amazon.com Inc (AMZN) Earnings Update: Q3 2026

Amazon reported Q3 2026 net sales up 12% year over year to $201.9 billion, narrowly below the $202.3 billion consensus estimate.

AMZN $2.6T

SixSigmaCapital: Navigating the Financial Markets Oct 31 7 clicks

Expert Call | Optical Module Ramps, Lumentum vs. Coherent Momentum, Server CPU, and Advanced Packaging Constraints

AAOI, Lumentum and Coherent 800G ramps, NVIDIA Rubin timing, and AMD, Intel and Arm server CPU demand frame an expert call on AI…

LITE $62BCOHR $41B

P Equity Research Oct 31 1 click

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $20B

Stock Thoughts Oct 31 4 clicks

Anthropic’s Growth is Slowing: Is AI Capex Next? | The Weekly Wrap

Anthropic’s revenue growth slowed from 147% in Q2 to 45% in Q3, raising questions about AI capital spending as Amazon holds capex flat.

AMZN $2.6T

Steve Eisman Oct 30 5 clicks

American Tower's Starlink Opportunity

American Tower could gain $1.13 to $3.54 in AFFO per share if Starlink accesses 80,000 U.S. cell sites and becomes a fourth major tenant.

AMT $88B

Dane Bowler Oct 30 3 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B

Cestrian Capital Research Oct 30 3 clicks

AstraZeneca (AZN) Q3 FY12/26 Earnings Review

AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.

AZN $270B

Cestrian Capital Research Oct 30 2 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B

Cestrian Capital Research Oct 30 1 click

SK hynix: Despite Their Premium To The Korean Shares, The U.S. ADRs Are A Bargain

SK hynix's U.S. ADR trades at a valuation discount despite AI-driven memory demand, with 50% of 2027–2028 capacity under long-term…

SKHY $806B

Adam Schadt Oct 30 2 clicks

BSX · long

Boston Scientific CORP

Boston Scientific, the interventional cardiac-device leader, is rated long after a share-price and P/E decline tied to slower market growth…

BSX $64B

Value Investors Club Jun 29 1 click

Thursday Tailwinds #8: Sep 24, 2026

ResMed benefits as Eli Lilly-funded sleep-apnoea diagnoses expand PAP demand, while NOV’s geothermal cutters and Po Valley’s unhedged…

RMD $33B

Trade Ideas Flow Sep 24 1 click

[scuttleslops] AAPL, SHOP, Databricks, Lonza

Apple has ceded frontier AI to partners like Google while planning AI-native glasses, camera-equipped AirPods and a smart-home hub over the…

AAPL $4.8T

scuttleblurb Sep 24 7 clicks

Intuitive Surgical ($ISRG) Deep Dive

Intuitive Surgical faces new US robotic-surgery challengers from Medtronic’s Hugo RAS and J&J’s Ottava after building a 12,000-system da…

ISRG $150BMDT $127B

Jimmy's Journal Sep 24 1 click

AMD: AI Agents Give Its Memory Advantage A Much Bigger Market

AMD’s MI455X offers 432 GB of HBM4, 50% more memory than Nvidia’s Rubin, positioning it for memory-intensive enterprise AI agents.

AMD $798B

Simple Investment Ideas Sep 24 3 clicks

Research Roundup Vol. LIII

Micron’s customer agreements, Analog Devices’ acquisitions, Ondas’ GATE deal and Baker Hughes’ power systems position them for AI…

MU $946BADI $201B

Monte Independent Investment Research Sep 23 4 clicks

Intel: The Party Is Only Getting Started

Intel reported Q2 2026 revenue of $16.13 billion, up 25.4%, as AI PCs and data-center CPUs lifted margins and narrowed foundry losses.

INTC $348B

Danil Sereda Sep 23 3 clicks

CoreWeave, Inc (CRWV)

CoreWeave funds GPU data-center expansion with debt backed by $104 billion in contracted revenue, while GPU cloud rentals generate roughly…

CRWV $34B

SixSigmaCapital: Navigating the Financial Markets Sep 22 9 clicks

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Texas Instruments, ON Semiconductor and Vishay are rated Accumulate on rising robotics demand for analog, power and discrete chips after a…

TXN $285BON $28B

Cestrian Capital Research Sep 22 6 clicks

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Abbott’s Exact Sciences acquisition raises leverage, leaving Medical Devices’ 8% growth and 33.9% margin to carry cash flow until…

ABT $191B

PV Research Sep 22 1 click

Sunday, November 1, 2026

Myles on X

Barbarian Capital on X

Myles on X

Negligible Capital on X

Paradis on X

Myles on X

junkbondinvestor on X

Fajasy on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 69 of 272

X accounts we follow

Investor letters we follow

Sectors